Search

Your search keyword '"Messenger RNA -- Technology application"' showing total 86 results
Start Over Descriptor "Messenger RNA -- Technology application"
86 results on '"Messenger RNA -- Technology application"'

1. Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma

Subjects
Meiji Seika Pharma Company Ltd. -- Technology application, Vaccination -- Technology application, Respiratory tract diseases -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral diseases to protect public health KOSTAIVE, the world's first self-amplifying mRNA (sa-mRNA) [...]

Published
2024

2. Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA COVID-19 Vaccine for Protection against JN.1 Strain, to be Distributed in Japan by Meiji Seika Pharma

Subjects
Meiji Seika Pharma Company Ltd. -- Technology application, Vaccination -- Technology application, Messenger RNA -- Technology application, Public health -- Technology application, Vaccines -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Business, Business, international
Abstract

Approval underscores CSL and Arcturus Therapeutics' commitment to delivering disruptive technologies to combat COVID-19 and other respiratory viral diseases to protect public health * KOSTAIVE([R]), the world's first self-amplifying mRNA [...]

Published
2024

3. University of Warsaw Researcher Details Research in Drugs and Therapies (Trinucleotide cap analogs with triphosphate chain modifications: synthesis, properties, and evaluation as mRNA capping reagents)

Subjects
Immunotherapy -- Technology application, Messenger RNA -- Technology application, Drugs -- Technology application, Technology application, Health
Abstract

2024 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators publish new report on drugs and therapies. According to news reporting from Warsaw, Poland, [...]

Published
2024

4. Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles

Subjects
Nanoparticles -- Technology application, Messenger RNA -- Technology application, Abdominal aneurysm -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

Hamilton, Bermuda, July 19, 2024 (GLOBE NEWSWIRE) -- Study shows significant reduction in aorta dilation, delayed rupture and lower mortality in established animal model of abdominal aortic aneurysm Altamira's SemaPhore(TM) [...]

Published
2024

5. Cipla to Invest Additional 3 Mn Euro in MRNA Technology Company Ethris

Subjects
High technology industry -- Technology application, Messenger RNA -- Technology application, Technology application, Banking, finance and accounting industries
Abstract

Cipla on Tuesday announced that its wholly-owned subsidiary Cipla will invest an additional 3 million euros in Ethris GmbH, a global leader in mRNA technology for respiratory treatments. This additional [...]

Published
2024

6. Researchers from Eisai & Co. Ltd. Provide Details of New Studies and Findings in the Area of Coronavirus (Understanding the Manufacturing Process of Lipid Nanoparticles for Mrna Delivery Using Machine Learning)

Subjects
Medical research -- Technology application, Medicine, Experimental -- Technology application, Nanoparticles -- Technology application, Messenger RNA -- Technology application, Machine learning -- Technology application, Vaccines -- Technology application, Severe acute respiratory syndrome -- Technology application, Coronaviruses -- Technology application, Technology application, Health
Abstract

2024 JUL 3 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on RNA Viruses - Coronavirus have been published. According to news reporting [...]

Published
2024

7. Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform & BioXp mRNA solutions and announces new leadership

Subjects
DNA -- Technology application, DNA synthesis -- Technology application, Messenger RNA -- Technology application, Enzymes -- Technology application, Technology application, General interest, News, opinion and commentary
Abstract

SAN DIEGO: Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in strategy enabled by the commercial availability of its [...]

Published
2024

8. Cancer vaccine given to rst UK patients. Revolutionary jab uses mRNA technology behind Covid inoculations to ag tumour to immune system

Subjects
Vaccination -- Technology application, Tumors -- Technology application, Immune system -- Technology application, Cancer patients -- Technology application, Messenger RNA -- Technology application, Cancer vaccines -- Technology application, Technology application, General interest, News, opinion and commentary
Abstract

Byline: Michael Searles THE rst UK patients have received a revolutionary cancer vaccine as part of a global trial. Scientists are using the MRNA technology behind Covid jabs to create [...]

Published
2024

9. Findings from University of Applied Sciences Advance Knowledge in Gene Therapy (Novel suspension retroviral packaging cells generated by transposition using transposase encoding mRNA advance vector yields and enable production in bioreactors)

Subjects
Genes -- Technology application, Gene therapy -- Technology application, Messenger RNA -- Technology application, Physical fitness -- Technology application, Packaging -- Technology application, Technology application, Health
Abstract

2023 APR 22 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Fresh data on gene therapy are presented in a new report. According [...]

Published
2023

10. Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit

Subjects
Messenger RNA -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

HAMILTON, BERMUDA , Jan. 08, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics to Present at 3[sup.rd] Annual mRNA-Based Therapeutics Summit Altamira's two flagship programs, AM-401 and AM-411, designed for KRAS-driven cancer [...]

Published
2024

11. 3rd Annual mRNA-Based Therapeutics Summit: Altamira Therapeutics to Present

Subjects
Messenger RNA -- Technology application, Osteoarthritis -- Technology application, Technology application, General interest, News, opinion and commentary
Abstract

HAMILTON: Altamira Therapeutics Ltd. ('Altamira'), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, announced that it will be presenting at the 3rd Annual mRNA-Based Therapeutics Summit, [...]

Published
2024

12. Omicron specific mRNA-based booster vaccine approved for emergency use

Subjects
Messenger RNA -- Technology application, Vaccines -- Technology application, Technology application, News, opinion and commentary, Regional focus/area studies
Abstract

Bangladesh, June 20 -- New Delhi, 20 June (Hindustan Times). The Department of Biotechnology (DBT) has announced that the mRNA-based booster vaccine for the Omicron variant of corona, developed using [...]

Published
2023

13. Using biocatalysis, EnginZyme Produces a Crucial mRNA Vaccine Ingredient

Subjects
Catalysis -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application, Technology application, General interest, News, opinion and commentary
Abstract

STOCKHOLM: EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries, announced that it had [...]

Published
2023

14. EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis

Subjects
Biological products industry -- Technology application, Catalysis -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application, Logistics -- Technology application, Fine chemicals -- Technology application, Technology application, News, opinion and commentary
Abstract

STOCKHOLM--(BUSINESS WIRE)--Oct 25, 2023-- EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries, announced [...]

Published
2023

15. Enparticle Revolutionizes mRNA Vaccine Production With Advanced Microfluidic Technology

Subjects
Microfluidics -- Technology application, Messenger RNA -- Technology application, Electronics industry -- Technology application, Vaccines -- Technology application, Technology application, Electronics industry, Business, Business, international
Abstract

M2 PRESSWIRE-September 21, 2023-: Enparticle Revolutionizes mRNA Vaccine Production With Advanced Microfluidic Technology (C)1994-2023 M2 COMMUNICATIONS RDATE:21092023 Enparticle is leading the way in the field of Bio-Technology, Electronics (Semiconductor), Medicine, [...]

Published
2023

16. PCI Biotech Holding ASA: European patent for mRNA delivery with fimaNAc

Subjects
Skin diseases -- Technology application, Biotechnology -- Technology application, Messenger RNA -- Technology application, Technology application, Business, international
Abstract

Oslo: PCI Biotech Holding ASA has issued the following news release: PCI Biotech (OSE: PCIB), a biopharmaceutical company, today announces that the European Patent Office (EPO) has informed PCI Biotech [...]

Published
2023

17. Arcturus Lands $9M for Inhaled mRNA CF Treatment: BIOPHARMA: Cystic Fibrosis Foundation Funding 'Disruptive Technology'

Author

Kastner, Jennifer

Subjects
Biological products industry -- Technology application, Cystic fibrosis -- Drug therapy, Messenger RNA -- Technology application, Technology application, Business, Business, regional
Abstract

Messenger RNA-specialty biopharma powerhouse Arcturus Therapeutics (Nasdaq: ARCT) has been awarded an additional $9 million by the Cystic Fibrosis (CF) Foundation to advance the development of an inhalable technology to [...]

Published
2023

18. India : Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology

Subjects
Messenger RNA -- Technology application, Vaccines -- Technology application, Pharmaceutical biotechnology -- Technology application, Technology application, Business, international
Abstract

The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and supported under the Mission COVID Suraksha, [...]

Published
2023

19. OMICRON-SPECIFIC MRNA-BASED BOOSTER VACCINE DEVELOPED USING THE INDIGENOUS PLATFORM TECHNOLOGY

Subjects
Biotechnology industry -- Product development, Messenger RNA -- Technology application, Vaccines -- Product development, Pharmaceutical biotechnology -- Technology application, Technology application, News, opinion and commentary
Abstract

NEW DELHI, India -- The following information was released by the Government of India: by PIB Delhi The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine [...]

Published
2023

20. Broken hearts in mice repaired using mRNA coronavirus vaccine technology

Subjects
T cells -- Technology application, Messenger RNA -- Technology application, Genetic engineering -- Technology application, Coronaviruses -- Technology application, Genetically modified organisms -- Technology application, Technology application
Abstract

Michael Le Page IMMUNE cells in the bodies of mice have been temporarily reprogrammed to repair damaged hearts by removing scar tissue, thanks to the technology used in the mRNA [...]

Published
2022

21. Broken hearts in mice repaired using mRNA coronavirus vaccine technology

Subjects
T cells -- Technology application, Messenger RNA -- Technology application, Genetic engineering -- Technology application, Coronaviruses -- Technology application, Genetically modified organisms -- Technology application, Technology application
Abstract

Michael Le Page IMMUNE cells in the bodies of mice have been temporarily reprogrammed to repair damaged hearts by removing scar tissue, thanks to the technology used in the mRNA [...]

Published
2022

22. 2 mRNA technology may treat stubborn diseases

Subjects
Messenger RNA -- Technology application, Vaccines -- Technology application, Viral proteins -- Technology application, Technology application
Abstract

Michael Le Page 2022 could be the year when we find out whether mRNA vaccine technology can be used for a lot more than just making vaccines. The hope is [...]

Published
2022

23. 2 mRNA technology may treat stubborn diseases

Subjects
Messenger RNA -- Technology application, Vaccines -- Technology application, Viral proteins -- Technology application, Technology application
Abstract

Michael Le Page 2022 could be the year when we find out whether mRNA vaccine technology can be used for a lot more than just making vaccines. The hope is [...]

Published
2022

24. Sensible Biotechnologies Announces Partnership with Ginkgo Bioworks to Develop Novel mRNA Manufacturing Platform

Subjects
Homeopathy -- Materia medica and therapeutics, Biotechnology -- Technology application, Biotechnology industry -- Alliances and partnerships, Messenger RNA -- Technology application, Therapeutics -- Technology application, Vaccines -- Technology application, Technology application, General interest, News, opinion and commentary
Abstract

OXFORD, United Kingdom: Sensible Biotechnologies has issued the following news release: Sensible Biotechnologies, an early stage biotechnology company, today announced a partnership to develop an in vivo microbial mRNA manufacturing [...]

Published
2023

25. Sensible Biotechnologies Announces Partnership with Ginkgo Bioworks to Develop Novel mRNA Manufacturing Platform

Subjects
Biotechnology -- Technology application, Biotechnology industry -- Alliances and partnerships, Messenger RNA -- Technology application, Vaccines -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

Through this partnership, Sensible and Ginkgo aim to develop an in vivo alternative to conventional in vitro mRNA production technology OXFORD, United Kingdom, April 3, 2023 /PRNewswire/ -- Sensible Biotechnologies, [...]

Published
2023

26. Pfizer begins study of mRNA-based next generation flu vaccine program

Subjects
Pfizer Inc. -- Technology application -- Planning, Influenza vaccines -- Planning -- Technology application, Messenger RNA -- Technology application, Influenza -- Technology application, Pharmaceutical industry -- Technology application -- Planning, Company business planning, Technology application, Business, News, opinion and commentary
Abstract

Pfizer announced that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose quadrivalent mRNA vaccine against [...]

Published
2021

27. Vaxelerando; Developing vaccines

Subjects
Messenger RNA -- Technology application, Technology application, Business, Economics, Business, international, Comirnaty (Vaccine) -- Product development, Spikevax (Vaccine) -- Product development
Abstract

Scientists responded rapidly to the pandemic. Next time they could be even faster AS THE DELTA variant of covid-19 continues to spread across large parts of the world, the shame [...]

Published
2021

28. ExPLoRNA Therapeutics receives funding to advance its novel mRNA technology

Subjects
Biological products industry -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application, Technology application, Business, News, opinion and commentary
Abstract

Funding from the Bill & Melinda Gates Foundation will go toward understanding the benefits of novel cap analogs for therapeutic applications WARSAW, Poland, Dec. 7, 2022 /PRNewswire/ -- ExPLoRNA Therapeutics, [...]

Published
2022

29. Studies from Universidade Catolica Portuguesa Provide New Data on HIV/AIDS (mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV)

Subjects
HIV (Viruses) -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Messenger RNA -- Technology application, Tuberculosis -- Technology application, Malaria -- Technology application, Vaccines -- Technology application, AIDS (Disease) -- Technology application, Technology application, Health
Abstract

2023 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Malaria Weekly -- Investigators publish new report on HIV/AIDS. According to news reporting from Lisbon, Portugal, by NewsRx [...]

Published
2023

30. Sensible Biotechnologies Announces Partnership with Ginkgo Bioworks to Develop Novel mRNA Manufacturing Platform

Subjects
Homeopathy -- Materia medica and therapeutics, Biotechnology -- Technology application, Biotechnology industry -- Alliances and partnerships, Messenger RNA -- Technology application, Therapeutics -- Technology application, Vaccines -- Technology application, Technology application, Health
Abstract

2023 APR 19 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Sensible Biotechnologies, an early stage biotechnology company, announced a partnership to develop an in vivo [...]

Published
2023

31. 'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time (MRNA)

Subjects
United States. National Institutes of Health -- Technology application, Sanofi S.A. -- Technology application, Biotechnology -- Technology application, Messenger RNA -- Technology application, Coronaviruses -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Consumer news and advice, General interest
Abstract

Moderna The $10 billion biotech Moderna developed a potential coronavirus vaccine in record time, zooming past Big Pharma competitors. The company's CEO Stephane Bancel sat down with Business Insider to [...]

Published
2020

32. mRNA Leading Expert Kenneth Chien and Novalis LifeSciences' Marijn Dekkers Investing EUR 39M Series B2 Financing in mRNA Technology Platform Company eTheRNA

Subjects
Business plans -- Technology application, High technology industry -- Technology application, Messenger RNA -- Technology application, Business planning -- Technology application, Technology application, Banking, finance and accounting industries, Business
Abstract

NIEL, Belgium, Aug 23, 2022 (GLOBE NEWSWIRE via COMTEX) -- -- Financing round led by Novalis LifeSciences LLC eTheRNA ('the Company'), a leading mRNA technologies company, announced today that it [...]

Published
2022

33. Australia : Victorian mRNA Research Acceleration Grants Announced

Subjects
Medical research -- Technology application, Medicine, Experimental -- Technology application, Messenger RNA -- Technology application, Company financing, Technology application, Business, international, Monash University -- Technology application
Abstract

The Andrews Labor Government is fast-tracking innovative mRNA research projects with grants for Victorian scientists. Minister for Innovation, Medical Research and the Digital Economy Jaala Pulford today announced the first [...]

Published
2022

34. Integral Molecular and Optimeos Life Sciences Enter Partnership to Develop mRNA and DNA-Based Gene Therapies Using Molecular Targeting

Subjects
DNA -- Technology application, Genes -- Technology application, Viral antibodies -- Technology application, Gene therapy -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application -- Planning, Antibodies -- Technology application, Company business planning, Technology application, General interest, News, opinion and commentary
Abstract

PHILADELPHIA: Integral Molecular has issued the following news release: Integral Molecular and Optimeos Life Sciences announce a partnership to develop next-generation mRNA and DNA therapeutics that will use antibody-based molecular [...]

Published
2022

35. Integral Molecular and Optimeos Life Sciences Enter Partnership to Develop mRNA and DNA-Based Gene Therapies Using Molecular Targeting

Subjects
DNA -- Technology application, Genes -- Technology application, Viral antibodies -- Technology application, Gene therapy -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application -- Planning, Antibodies -- Technology application, Company business planning, Technology application, Business, News, opinion and commentary
Abstract

PHILADELPHIA, June 8, 2022 /PRNewswire/ -- Integral Molecular and Optimeos Life Sciences announce a partnership to develop next-generation mRNA and DNA therapeutics that will use antibody-based molecular targeting to direct [...]

Published
2022

36. Researchers from Helmholtz-Institute for Pharmaceutical Research Saarland Detail Findings in Nanoparticles (Lipid-Polymer Hybrid Nanoparticles for mRNA Delivery to Dendritic Cells: Impact of Lipid Composition on Performance in Different Media)

Subjects
Biochemistry -- Technology application, Lipids -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Nanoparticles -- Technology application, Messenger RNA -- Technology application, Infection -- Technology application, Dendritic cells -- Technology application, Polymers -- Technology application, Technology application, Health
Abstract

2023 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in nanoparticles. According to news reporting originating from Saarbrucken, [...]

Published
2023

37. Massively-parallel Microbial mRNA Sequencing (M3-Seq) reveals heterogenous behaviors in bacteria at single-cell resolution (Updated December 1, 2022)

Subjects
Bacteria -- Technology application, RNA sequencing -- Technology application, Messenger RNA -- Technology application, Technology application, Health
Abstract

2022 DEC 23 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting based on a preprint abstract, our journalists obtained the [...]

Published
2022

38. United States : Honeywell Collaborates With Walvax Biotech To Automate Chinas First Digital mRNA Covid-19 Vaccine Plant

Subjects
Honeywell Inc. -- Technology application, Automation -- Technology application, Biological products industry -- Technology application, Biotechnology -- Technology application, Messenger RNA -- Technology application, Real estate management -- Technology application, Vaccines -- Technology application, Mechanization -- Technology application, Technology application, Business, international
Abstract

Honeywell today announced its successful work with Walvax Biotechnology Co., Ltd. in providing automation control solutions to achieve highly intelligent and digitized vaccine production for China's first mRNA COVID-19 vaccine [...]

Published
2022

39. Moderna, Excision each enter HIV battle with mRNA and CRISPR tech

Author

LaHucik, Kyle

Subjects
Merck & Company Inc. -- Technology application, Biological products industry -- Technology application, HIV (Viruses) -- Technology application, Vaccination -- Technology application, Messenger RNA -- Technology application, Highly active antiretroviral therapy -- Technology application, Vaccines -- Technology application, Pharmaceutical industry -- Technology application, Technology application, Biotechnology industry
Abstract

Byline: Kyle LaHucik Moderna and Excision BioTherapeutics are stepping into a battle with HIV, a 41-year epidemic that has confuddled drug developers and vaccine makers the world over. The COVID-19 [...]

Published
2022

40. Data from University Medical Center Hamburg-Eppendorf Advance Knowledge in Prostate Cancer [Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in ...]

Subjects
Cancer diagnosis -- Technology application, Physical fitness -- Technology application, Medical centers -- Technology application, Prostate cancer -- Technology application, Messenger RNA -- Technology application, Androgens -- Technology application, Workflow software, Tumors, Obesity, Technology, Health care industry, Cancer metastasis, RNA, Editors, Technology application, Health
Abstract

2019 SEP 28 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Oncology - Prostate Cancer have been published. According [...]

Published
2019

41. New Regenerative Medicine Findings from Biotechnology Research Institute for Drug Discovery Reported (mRNA and miRNA expression profiles in an ectoderm-biased substate of human pluripotent stem cells)

Subjects
Biotechnology -- Technology application, MicroRNA -- Technology application, Biomedical engineering -- Technology application, Stem cells -- Technology application, Stem cell research -- Technology application, Drug discovery -- Technology application, Messenger RNA -- Technology application, Stem cell transplantation -- Technology application, Anopheles, Biological markers, Medical research, RNA, Editors, Technology application, Health
Abstract

2019 SEP 2 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Data detailed on Biomedical Engineering - Regenerative Medicine have been presented. According to news [...]

Published
2019

42. Data on Oral Cancer Discussed by Researchers at Texas A&M University (Nanoparticle-based assay for detection of S100P mRNA using surface-enhanced Raman spectroscopy)

Subjects
Mouth cancer -- Technology application, Protein binding -- Technology application, Physical fitness -- Technology application, Cancer research -- Technology application, Messenger RNA -- Technology application, Raman spectroscopy -- Technology application, Spectroscopy, Cancer, Biological markers, Calmodulin, Obesity, Technology, Binding proteins, RNA, Editors, Technology application, Health
Abstract

2019 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- New research on Oncology - Oral Cancer is the subject of a [...]

Published
2019

43. Messenger RNA technology shows promise for developing infectious disease therapeutics

Subjects
United States. Army. Medical Research Institute of Infectious Diseases -- Technology application, Cell Press -- Technology application, Communicable diseases -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Homeopathy -- Materia medica and therapeutics, Messenger RNA -- Technology application, Therapeutics -- Technology application, Vaccines -- Technology application, Periodical publishing -- Technology application, Technology application, Business, Health, Health care industry
Abstract

2022 JUL 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Army scientists and industry partners were among the first to [...]

Published
2022

44. United States : Pfizer Starts Study Of Mrna-based Next Generation Flu Vaccine Program

Subjects
Pfizer Inc. -- Technology application -- Planning, Business plans -- Technology application, Influenza vaccines -- Planning -- Technology application, Messenger RNA -- Technology application, Influenza -- Technology application, Business planning -- Technology application, Company business planning, Technology application, Business, international
Abstract

Pfizer Inc. announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a single dose quadrivalent mRNA [...]

Published
2021

45. Pfizer Started Study of mRNA-Based Next Generation Flu Vaccine Program

Subjects
Pfizer Inc. -- Technology application -- Planning, Influenza vaccines -- Planning -- Technology application, Messenger RNA -- Technology application, Influenza -- Technology application, Company business planning, Technology application, General interest, News, opinion and commentary
Abstract

NEW YORK: Pfizer Inc. (NYSE: PFE) announced today that the first participants have been dosed in a Phase 1 clinical trial to evaluate the safety, tolerability, and immunogenicity of a [...]

Published
2021

46. Researchers at Zhejiang University Release New Data on COVID-19 (Emerging Mrna Technologies: Delivery Strategies and Biomedical Applications)

Subjects
Medical research -- Technology application, Medicine, Experimental -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application, Coronaviruses -- Technology application, Technology application, Health
Abstract

2022 MAY 25 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- Current study results on Coronavirus - COVID-19 have been published. According to news originating from [...]

Published
2022

47. COVID-19 MRNA VACCINE THAT USES FUNDAMENTAL PENN TECHNOLOGY RECEIVES FDA APPROVAL

Subjects
United States. Food and Drug Administration -- Technology application, Pfizer Inc. -- Research agreements, Vaccination -- Technology application, Messenger RNA -- Technology application, Vaccines -- Technology application, Pharmaceutical industry -- Research agreements, Technology application, News, opinion and commentary
Abstract

PHILADELPHIA, PA -- The following information was released by Penn Medicine: Pfizer/BioNTech's vaccine to prevent COVID-19 uses fundamental modified mRNA technology created by researchers at the Perelman School of Medicine [...]

Published
2021

48. Ignite LSF announces first grant for mRNA vaccine technology

Subjects
Messenger RNA -- Technology application, Technology application, Biotechnology industry
Abstract

The grant will be for three years and will fund research to develop the platform technologies for RNA vaccine development Ignite Life Science Foundation (LSF) has announced its first grant [...]

Published
2021

49. Single-cell mRNA cytometry via sequence-specific nanoparticle clustering and trapping

Subjects
Cancer treatment -- Technology application, Physical fitness -- Technology application, Prostate cancer -- Care and treatment -- Technology application, Messenger RNA -- Technology application, Biological markers -- Technology application, Technology application, Health, University of Toronto -- Innovations -- Technology application
Abstract

2018 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Prostate cancer is the second most common cancer in men and the [...]

Published
2018

50. India : Department of Biotechnology provides under Mission COVID Suraksha for Gennova Biopharmaceuticals Ltd.'s novel mRNA-based COVID 19 Vaccine candidate HGCO19

Subjects
Biological products industry -- Technology application, Medical research -- Technology application, Medicine, Experimental -- Technology application, Biopharmaceutics -- Technology application, Messenger RNA -- Technology application, Pharmaceutical biotechnology -- Technology application, Technology application, Business, international
Abstract

The Department of Biotechnology (DBT), Ministry of Science & Technology has announced that it has approved additional funding towards clinical studies of India's'first of its kind' mRNA-based COVID-19 vaccine - [...]

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results